CHO Pharma, Inc. (TPEX:6586)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.05
-0.05 (-0.16%)
Dec 5, 2025, 1:56 PM CST
-44.55%
Market Cap 6.65B
Revenue (ttm) 3.21M
Net Income (ttm) -230.38M
Shares Out 214.01M
EPS (ttm) -1.08
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 295,453
Average Volume 281,326
Open 31.10
Previous Close 31.10
Day's Range 30.60 - 31.80
52-Week Range 28.10 - 68.80
Beta -0.54
RSI 47.53
Earnings Date Nov 13, 2025

About CHO Pharma

CHO Pharma, Inc., engages in research and development of biotechnology in Taiwan. It develops glycoengineering platform technologies, including SAR-based glycoengineered biobetters; glycosite-specific antibody-drug conjugates (ADCs); novel antibodies and vaccines targeting novel carbohydrate antigens; and programs using its glycoengineering technologies. The company also provides CHOptimax, an in vitro enzymatic one-pot process that converts naked antibodies into glycoengineered biobetter or ADC. In addition, the company develops CHO-H01, which... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 47
Stock Exchange Taipei Exchange
Ticker Symbol 6586
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.